🌐 EnglishEN

AI Cure is a research tool showing open data. Not medical advice. Discuss with your doctor. Terms

← Trials
🧪

Pain and Comfort Levels During Heel Stick Blood Sampling in Newborns

RecruitingNAAges 1 Day - 1 MonthAllTarsus University
NCT07081048 on ClinicalTrials.gov ↗
💬

In plain words

What the trial is, and whether it could suit you

Aim: The study was designed to determine the effect of Buzzy® and Shotbloker® application on pain and comfort levels in newborns during heel pricking. Method:The study was a randomised controlled trial. The study sample consisted of 159 newborns (Buzzy: 53, Shotbloker: 53, control: 53) who had heel pricks between March 2025 and December 2025 at the Samandağ State Hospital Neonatal Care Unit. The data collection tools used will be the Newborn Information Form, the Newborn Pain Scale, the Newborn Comfort Behaviour Scale, and the Buzzy® and Shotbloker® devices. In the intervention group, the Buzzy® and Shotbloker® devices will be applied before and after heel pricking, while the control group will receive routine care. The infants' pain and comfort levels will be assessed by the nurse before and after the procedure.

Sign in to get the eligibility rules as simple questions to take to your doctor.

Sign in
📋 Eligibility rules (as published)
Inclusion Criteria: * The baby must be full-term (38-42 weeks), * No analgesic administration up to 8 hours prior to the procedure, * No pain prior to the procedure, * No chronic or metabolic disease, * Born at least 24 hours prior, * Being in the hospital during the study period Exclusion Criteria: * The baby is not full-term, * Analgesic medication has been administered within 8 hours prior to the procedure, * The baby has a chronic or metabolic disease, * The baby requires oxygen support, * The baby cannot be fed orally, * The baby is not in the hospital on the dates the study will be conducted and the parents do not agree to participate in the study.
💊

What it tests

  • Buzzy®.Group
  • ShotBlocker Group
📍

Where

1 site
Tarsus University
Mersin, Turkey (Türkiye)
🤝 Taking part is your choice, and you can leave at any time. Only the trial team can confirm you are eligible — always decide together with your own doctor.
🛡️

AI Cure shows public evidence (Open Targets, ClinicalTrials.gov, PubMed, openFDA, DepMap, AlphaFold) with its source, and AI summaries that cite it — not medical advice and not a cure. Treatment decisions belong with your doctor. Research ideas are shared only with approved researchers and labs, who can test them. In an emergency call your local emergency number (112 in India and Europe, 911 in the US). AI Cure Terms of Use · Privacy